Biotech firm Aperion Biologics ready to launch first device in Europe

Aperion Biologics, one of several San Antonio-based bioscience firms that had an opportunity to pitch to potential investors on Thursday during the World Stem Cell Summit's inaugural RegMed Capital Summit, is only weeks away from rolling out its initial product.

http://ift.tt/1vSdej7